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COVID-19 can cause serious conditions in both comorbid and elderly patients; hence, they need to be 
given proper follow-up treatment. This study aimed to determine the association between patient 
characteristics and disease outcomes of COVID-19 in Jember, Indonesia. This research is an analytic 
observational study with a cross-sectional approach. The sample was 304 patients confirmed positive 
for COVID-19 at the COVID-19 referral hospitals in Jember. This study used medical record data 
analyzed using both univariate and bivariate tests. Patient characteristics related to the disease 
outcomes in patients who were positive for COVID-19 in Jember, are as follows: age (p = 0.000), 
clinical symptoms (p = 0.017), comorbidities (p = 0.000), and complications (p = 0.000). The unrelated 
variables were sex (p = 0.455), education level (p = 1.000), domicile (p = 1.000), occupation (p = 
0.322), and smoking history (p = 0.147). Patients most at risk of developing fatal outcomes are those 
with complications. Patient characteristics associated with the disease outcomes in patients positive 
for COVID-19 were age, clinical symptoms, comorbidities, and complications. While, those that were 
not related to the disease outcomes in patients were sex, education level, occupation, domicile, and 
smoking history. 
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INTRODUCTION 
COVID-19 is a new disease caused by 
Severe Acute Respiratory Syndrome 
Coronavirus 2 (SARS-CoV-2) infection. The 
pathogen that causes COVID-19 is the 
Betacoronavirus which belongs to the 
Sarbecovirus subgenus. In December 2019, 
at Wuhan City, Hubei Province, China, this 
disease appeared for the first time with the 
discovery of cases of respiratory disease with 
distinctive findings on radiological images.1  
On March 11, 2020, WHO declared that 
the COVID-19 outbreak became a global 
pandemic.2 One study suggested that male 
patients and those with anorexia may have 
worsening disease progression.3 Older 
patients (> 65 years) with comorbidity and 
ARDS have a high risk of death.4 COVID-19 
patients from the older age groups have 
much more severe disease and have a worse 
response to treatment than younger age 
groups5. Men with COVID-19 infection have 
> 50% higher risk of severe infection and 
death than women6. Symptoms of fever are 
most common in patients and strongly 
associated with the patient's clinical status7, 
besides that smokers are susceptible to 
respiratory viruses.8 
This global pandemic has affected all 
levels of society, both in villages and cities. 
Health staff, social workers, and educators 
have a higher risk of severe SARS-CoV-2 
infection.9 The government has made much 
effort. Almost the entire area of Jember 
regency was currently categorized into an 
orange zone with a medium risk level based 
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on data published by the Provincial 
Government of East Java.10 COVID-19 cases 
in Jember were increasing, with 620 positive 
cases as of September 9, 2020, 513 recovered 
cases, and 43 deaths. The Case Fatality Rate 
(CFR) was 6.94%.11 There is still no definite 
vaccine and drug to deal with COVID-19 
cases, while the spread of COVID-19 is 
significantly high even though the mortality 
rate is low. COVID-19 can cause severe 
conditions in elderly patients and those with 
comorbidity; therefore, it is essential to know 
the association between the characteristics of 
a positive patient with COVID-19 and the 
disease outcomes so that the patient can be 
diagnosed be provided with proper 
management. 
 
MATERIAL AND METHODS 
Study design and participants  
This study was an observational analytic 
with a cross-sectional approach. This was 
conducted at three COVID-19 referral 
hospitals in Jember, namely Kaliwates 
Hospital, Jember Klinik Hospital, and Citra 
Husada Hospital, from August 2020 to 
February 2021. The population of this study 
was all patients who tested positive for 
COVID-19 at those COVID-19 Referral 
Hospitals from April to November 2020. The 
sampling technique used was total sampling 
with a number of samples of 304. This study 
utilized the patients' medical records as the 
instrument. The independent variables of this 
study were age, sex, level of education, 
occupation, domicile, clinical symptoms, 
history of comorbidity, history of smoking, 
and complications. In contrast, the dependent 
variable was the patient's disease outcomes. 
This study has received ethical approval from 
the Ethics Commission of the Faculty of 
Medicine, University of Jember.  
 
Procedures 
This research began with population 
determination, namely, patients tested 
positive for COVID-19 at the Referral 
Hospitals for COVID-19 in Jember. Sample 
collection was conducted by using a total 
sampling technique with the following 
inclusion criteria: patients tested positive for 
COVID-19 with evidence of positive RT-
PCR swabs and or Fast Molecular Test 
(TCM) and the exclusion criteria as follows: 
patients who were tested positive for COVID-
19 with medical record data that did not meet 
the requirements set by the researchers. The 
medical record data was declared eligible if it 
contains at least 5 of the nine patient 
characteristics determined by the researchers. 
After collecting the sample, the patient's 
characteristics were recorded and grouped 
according to the disease outcome of the 
patients who tested positive for COVID-19 
based on the medical record data. 
 
Statistical analysis 
This study utilized univariate and 
bivariate analyses. Univariate analysis was 
performed by calculating the distribution and 
percentage of each variable. Bivariate 
analysis was carried out to determine the 
association between age, sex, education level, 
occupation, domicile, clinical symptoms, 
comorbidity history, smoking history, and 
complications with patient's disease outcome 
who were tested positive for COVID-19 in 
Jember. The Chi-Square Test was the main 
statistical test with a p <0.05 or 95% 
confidence level. If the Chi-Square Test 
requirements were not fulfilled, then the 




Sociodemographic and clinical 
characteristics of patients who tested positive 
for COVID-19 are shown in Table 1. Patients 
who tested positive for COVID-19 in Jember 
were mostly aged ≥ 45 years, with a total of 
154 (50.7%) patients of different types. Male 
patients of 156 patients (51.3%). 245 (80.6%) 
patients had met the 9-year compulsory 
education level. Two hundred thirty-one 
patients were indoor workers (76%), and the 
majority of the patients lived in cities with as 
many as 189 (62.2%) patients. A total of 257 
(84.5%) patients had clinical symptoms. A 
total of 272 (89.5%) patients had no smoking 
history, and 32 (10.5%) patients had a 
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smoking history. A total of 105 (34.5%) 
patients had comorbidity. A total of 40 
(13.2%) patients had complications. Disease 
outcomes in patients confirmed positive for 
COVID-19 in Jember are as follows: 270 
(88.8%) patients recovered, and 34 (11.2%) 
patients died. 
 
Table 1. Sociodemographic and clinical 







Age    
< 45 Years 150 49.3 
≥ 45 Years 154 50.7 
Sex   
Male 156 51.3 
Female 148 48.7 
Level of education    
Finished the 9-year 
compulsory education 245 80.6 
Unfinished the 9-year 
compulsory education 59 19.4 
Occupation    
Indoor 231 76 
Outdoor 73 24 
Domicile    
City 189 62.2 
Village  115 37.8 
Clinical symptoms   
Have clinical 
symptoms 257 84.5 
 
Have no clinical 
symptoms 47 15.5 
 
Comorbidity history   
With comorbidity 105 34.5 
Without comorbidity 199 65.5 
Smoking history   
Smoking 32 10.5 
Not Smoking 272 89.5 
Complications   
With complication 40 13.2 
Without complication 264 86 
Disease outcome   
Death 34 11.2 
Recovery  270 88.8 
 
The clinical symptoms, comorbidity, and 
complications were experienced by patients 
who tested positive for COVID-19 in this 
study. The most frequently occurring clinical 
symptom was cough in 167 (54.9%) patients, 
and the least frequently occurring was chest 
pain in 6 (2%) patients. The most common 
comorbidity among the patients was 
hypertension - cardiovascular disease in 46 
(15.1%) patients, and the least common was 
COPD in 1 (0.3%) patients. The most 
frequent complication experienced by 
patients was ARDS in 25 (8.22%) patients 
(Table 2). 
The association between patient 
characteristics and disease outcomes in 
patients tested positive for COVID-19 in 
Jember, as follows: age (p-value = 0.000), 
clinical symptoms (p-value = 0.017), history 
of comorbidity (p-value = 0.000), and 
complications (p-value = 0.000). Meanwhile, 
the unrelated variables were sex (p = 0.455), 
education level (p = 1.000), domicile (p = 
1.000), occupation (p = 0.322), and smoking 
history (p = 0.147). Patients aged≥ 45 years 
had a greater risk of 7.142 to experience a 
fatal outcome than those aged <45 years. 
Patients with clinical symptoms were 14.664 
times more likely to experience a fatal 
outcome than those who did not have clinical 
symptoms. Patients with a history of 
comorbidity had a 9.495 times greater risk of 
experiencing a fatal outcome than those who 
did not have comorbidity. Patients with 
complications had a 25.667 times greater risk 
of experiencing a fatal outcome than those 
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Table 2 Clinical symptoms, comorbidities, 
and complications experienced by patients 
confirmed positive for COVID-19 




symptoms   
Asymptomatic 47 15.5 
Fever 116 38.2 
Cough 167 54.9 



















Others 10 3.28 















Asthma 11 3.6 
COPD 1 0.3 
TBC 2 0.6 
Obesity 0  
Stroke 2 0.6 
Malignancy 2 0.6 




12         4 





ARDS 25 8.22 
Dyspnea 8 2.63 
Sepsis 5 1.64 
Cardiac arrest 2 0.65 
Others 1 0.33 
 
Table 3. Association between patient 
characteristics and disease outcomes of 
patients confirmed positive for COVID-19 
 
Characteristics 
Disease outcomes of 
COVID-19 positive 
patients in Jember  
P-Value OR 
 
Deaths Recovery   
n % n % 
  
Age  
 ≥ 45 Years 29 85.3 121 44.8 0.000 7.142 
< 45 Years 5 14.7 149 55.2   
Sex       
Male 20 58,8 136 50.4 0.455  








education 27 79.4 218 80.7 1.000  
Unfinished 
the 9th year 
compulsory 
education 7 20.6 52 19.3   
Occupation        
Indoor 26 76.5 205 75.9 1.000  
Outdoor 8 23.5 65 24.1   
Domicile        
City 18 52.8 171 63.3 0.322  
Village  16 47.1 99 36.7   
Clinical 
symptoms       
With clinical 
symptoms 34 100 223 82.6 0.017 14.664 
Without 
clinical 
symptoms 0 0 47 17.4   
Smoking 
history       
Smoking 6 17.6 26 9.6 0.147  
Not Smoking 28 82.4 244 90.4   
Comorbidity 
history       
With 
comorbidity 27 79.4 78 28.9 0.000 9.495 
Without 
comorbidity 7 20.6 192 71.1   
Complications       
With 
complication 22 64.7 18 6.7 0.000 25.667 
Without 
complication 12 35.3 252 93.3   
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DISCUSSION 
The Association between age and disease 
outcome  
The age group ≥ 45 years had the 
highest percentage of deaths, namely 85.3%. 
The results of this study are in line with a study 
proposing that old age is the strongest risk 
factor associated with fatal disease 
outcomes.12 COVID-19 patients aged ≥50 
years had a 15.4-fold higher risk of death than 
those aged <50 years. Increased mortality in 
elderly patients is due to decreased immune 
function.13 The induction of pro-inflammatory 
cytokines after infection is not sufficiently 
controlled by anti-inflammatory mechanisms 
in the elderly so that it has the potential to 
cause a poor prognosis.14 
 
Association between sex and disease 
outcome  
The percentage of male patients who 
died was 58.8%, while women were 41.2%. 
This suggests that there was no association 
between sex and hospital mortality in COVD-
19 patients because the mechanisms 
underlying sex were not strong enough to 
significantly influence hospital mortality due 
to a complex variety of causes.15 
 
The Association between education level 
and disease outcome  
The Chi-Square Test results prove that 
there is no association between education 
level and disease outcome in patients who 
were tested positive for COVID-19 in 
Jember. Previous research related to this has 
yet to be found. The level of education with 
the outcomes of the disease in patients was 
not significantly related because the disease 
outcome was related to the patient's condition 
and the severity of the disease and closely 
related to the treatment undertaken during 
hospitalization. 
 
The Association between occupation and 
disease outcome  
Chi-Square Test result proves no 
association between occupation and disease 
outcomes in patients who were tested positive 
for COVID-19 in Jember. The absence of an 
association between occupation and disease 
outcomes in patients may be due to 
differences in patient immunity when 
infected with COVID-19 and differences in 
their medical history. This study shows that 
more patients infected with COVID-19 work 
indoors than outdoors. This may be caused by 
environmental influences and the person's 
immunity. Patients who work in indoor areas, 
such as office workers, tend to work in closed 
areas, have low exposure to direct sunlight, 
and sometimes have less supportive air 
circulation. 
Meanwhile, for patients who work in 
outdoor areas, such as farmers – the majority 
occupation in Jember, it is possible to get 
sufficient sun exposure and good air 
circulation. This may provide benefits to 
strengthen the immune system. Sun exposure 
can trigger the formation of vitamin D 
naturally, which plays a role in supporting 
increased body immunity. Vitamin D has a 
direct antiviral effect, especially against 
coronavirus. Vitamin D can modulate and 
regulate the immune and oxidative responses 
to COVID-19 infection16.  
 
The association between domicile and 
disease outcome 
Based on the results of this study, it was 
found that there was no significant difference 
between the number of patient deaths due to 
COVID-19 in villages and cities. This may be 
caused by the fact that more rural residents 
did not follow the strict measure of COVID-
19 prevention behaviour than urban 
residents17. This study also shows that more 
patients infected with COVID-19 live in cities 
than in villages. One of the factors that cause 
the spread of COVID-19 is population 
density. Cities are places with a high 
population density. This allows the level of 
interaction between residents to be higher, 
causing any infectious disease to spread 
rapidly.18 
 
The association between clinical 
symptoms and disease outcome 
The Chi-Square Test results prove that 
there is an association between clinical 
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symptoms and disease outcomes in patients 
who are tested positive for COVID-19 in 
Jember. The clinical symptoms most 
frequently experienced by patients were 
cough (54.9%), fever (38.2%), and shortness 
of breath (33.2%). Patients with clinical 
symptoms were more likely to experience a 
fatal outcome than those who did not. Several 
factors are associated with the worsening 
clinical status in adults with COVID-19: 
fever, cough, and dyspnea.7 
 
The association between history of 
smoking and disease outcome 
Fisher's Exact Test results prove no 
association between smoking history and 
disease outcomes in patients who tested 
positive for COVID-19 in Jember. 6 (17.6%) 
patients with a history of smoking died. This 
study contradicts a study that stated that 
smoking status was associated with the 
severity of disease and mortality in COVID-
19 patients19. 
 
The association between comorbidity and 
disease outcome 
Patients with comorbidity have the 
highest mortality percentage at 27 (79.4%). 
Comorbidity most commonly found in 
patients were hypertension - a cardiovascular 
disease with as many as 46 (15.1%) patients, 
41 (13.5%) diabetes mellitus patients and 11 
(3.6%) asthma patients. Patients with more 
than one comorbidity are strongly associated 
with poor disease outcomes. This proves that 
the comorbidity history of more than one 
patient contributes to the complexity of the 
disease and often causes patients to have poor 
outcomes.20 The common comorbidity 
experienced by the COVID-19 patients were 
hypertension, diabetes mellitus, 
cardiovascular disease, cerebrovascular 
disease and chronic kidney disease.8 ACE2 
receptor expression is increased in several 
comorbid conditions such as hypertension 
and diabetes. SARS-CoV-2 attacks cells via 
the ACE2 receptor. Therefore, a history of 
comorbidity increases the severity of 
COVID-19 cases.21  
 
The association between complications 
and disease outcome 
Patients with complications had a 
greater percentage (64.7%) of death than 
those without complications. Complications 
that often occurred in patients in this study 
were ARDS (acute respiratory distress 
syndrome) in 25 (8.22%) patients, dyspnea in 
8 (2.63%) patients, and sepsis in 5 (1.64%) 
patients. ARDS was the most frequent 
complication of patients in this study. ARDS 
is a condition associated with various disease 
processes resulting in decreased lung growth 
and severe hypoxemia. Cytokine storms are 
one of the main features of ARDS in COVID-
19 patients. Pathological evidence of ARDS 
COVID-19 cases shows clear desquamation 
of pneumocytes, formation of hyaline 
membranes, and pulmonary edema.22 Sepsis 
is a life-threatening organ dysfunction caused 
by dysregulation of the immune system 
against infection.23 The pathophysiology of 
sepsis is related to an immune response 
initiated by pathogens that attack the host. 
Then the immune system fails to return to a 
homeostatic state, culminating in a 
pathological syndrome characterized by 
continued excessive inflammation and 
suppressed immunity.24 COVID-19 patients 
who suffer from sepsis show changes such as 
those found in septic shock, including 
changes in mental condition, dyspnea, 
reduced urine output, faster heart rate, weak 
pulse, and cold extremities.25 Dyspnea was 
statistically and significantly higher in the 
critical or deceased group.26 Dyspnea 
indicates poor lung function and a lack of 
oxygen. Therefore, COVID-19 patients with 
dyspnea may be more likely to develop the 
severe and critical disease.27 
 
 Limitations 
There are several limitations in 
implementing this research, including using 
medical record data as the data source. There 
may be incompleteness in implementing 
medical record data, which prevents the 
researchers from getting many more samples. 
This study used a cross-sectional approach; 
hence, it has not explained the course of the 
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disease in detail. In this study, not all patient 
characteristics related to disease outcomes 
were studied, so further research needs to be 
carried out in this regard. 
 
CONCLUSION 
Most of the patients who tested positive 
for COVID-19 in Jember aged ≥ 45 years 
were male. Patients were dominantly indoor 
workers, and the majority lived in cities. 
Patients who were most at risk of 
experiencing the outcome of death were 
patients who experienced complications. 
Patient characteristics related to the disease 
outcomes in patients who tested positive for 
COVID-19 in Jember were age, clinical 
symptoms, comorbidity history, and 
complications. Meanwhile, patients' 
unrelated disease outcomes were sex, 
education level, occupation, domicile, and 
smoking history. Related institutions are 
advised to be more careful in handling 
patients who are elderly, have a comorbidity, 
and experience complications to avoid more 
severe disease and death rates. People with 
advanced age and a history of comorbidity are 
always expected to be aware of the condition 
if they experience illness. Therefore, if they 
feel the symptoms of COVID-19, they are 
advised to examine the nearest health facility. 
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